Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MEM 1003 in Patients With Mild to Moderate Alzheimer's Disease

NCT00257673 is registered in ClinicalTrials.gov with Memory Pharmaceuticals as lead sponsor.

NCT NCT00257673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MEM 1003 in Patients With Mild to Moderate Alzheimer's Disease
Lead sponsor
Memory Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
October 31, 2007
Enrollment
183 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease